Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intravenous acetaminophen for persistent patent ductus arteriosus in preterm infants
IRCT20140907019076N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Rate of arterial duct closure. Started Aug 2020; status: completed.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20140907019076N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140907019076N3.